Literature DB >> 19793434

Costs incurred by patients with pulmonary tuberculosis in rural India.

K R John1, P Daley, N Kincler, O Oxlade, D Menzies.   

Abstract

SETTING: Vellore District, Tamil Nadu, India.
OBJECTIVE: To measure patient costs associated with diagnosis and the complete treatment of tuberculosis (TB).
DESIGN: Prospective structured interview of 100 new smear-positive adult patients being treated for TB in Tamil Nadu, India, selected evenly from 10 representative health facilities in the state. Direct (out-of-pocket) and indirect (lost-time) costs were quantified by period of illness using a standardised questionnaire, and univariate regression investigated predictors of total cost.
RESULTS: Seventy-four per cent of patients were male, with a mean age of 40.2 years. All were given a first-line regimen, and none had been previously treated. The mean direct cost was US$34.91 (SD $46.94), the mean indirect cost was $526.87 (SD $375.71), and the total mean cost per patient was $562.66 (SD $287.48). Twenty-five patients were admitted to hospital, at a mean cost of $279.43 (SD $142.88) per admission. Variation in costs was associated with admission.
CONCLUSION: TB patients in India incur large costs associated with TB illness. The greatest single cost was time lost during admission. Total patient costs represent 193% of the estimated monthly income of a manual labourer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19793434

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  17 in total

1.  There's no such thing as a free TB diagnosis: Catastrophic TB costs in Urban Uganda.

Authors:  Rebecca L Walcott; Justin B Ingels; Phaedra S Corso; Sarah Zalwango; Christopher C Whalen; Juliet N Sekandi
Journal:  Glob Public Health       Date:  2020-02-06

2.  How much do Indians pay for tuberculosis treatment? A cost analysis.

Authors:  P Sinha; M Carwile; A Bhargava; C Cintron; C Acuna-Villaorduna; S Lakshminarayan; A F Liu; N Kulatilaka; L Locks; N S Hochberg
Journal:  Public Health Action       Date:  2020-09-21

3.  The cost-effectiveness of tuberculosis preventive therapy for HIV-infected individuals in southern India: a trial-based analysis.

Authors:  Mai T Pho; Soumya Swaminathan; Nagalingeswaran Kumarasamy; Elena Losina; C Ponnuraja; Lauren M Uhler; Callie A Scott; Kenneth H Mayer; Kenneth A Freedberg; Rochelle P Walensky
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

4.  Systematic literature review to evaluate and characterize the health economics and outcomes research studies in India.

Authors:  Divya Mishra; Sunita R Nair
Journal:  Perspect Clin Res       Date:  2015 Jan-Mar

Review 5.  Costs to Health Services and the Patient of Treating Tuberculosis: A Systematic Literature Review.

Authors:  Yoko V Laurence; Ulla K Griffiths; Anna Vassall
Journal:  Pharmacoeconomics       Date:  2015-09       Impact factor: 4.981

6.  Catastrophic care-seeking costs as an indicator for lung health.

Authors:  S B Squire; Rachael Thomson; Ireen Namakhoma; Asma El Sony; Afranio Kritski; Jason Madan
Journal:  BMC Proc       Date:  2015-12-18

7.  Resource utilization pattern and cost of tuberculosis treatment from the provider and patient perspectives in the state of Penang, Malaysia.

Authors:  Muhammad Atif; Syed Azhar Syed Sulaiman; Asrul Akmal Shafie; Muhammad Asif; Zaheer-Ud-Din Babar
Journal:  BMC Health Serv Res       Date:  2014-08-19       Impact factor: 2.655

8.  Coping with tuberculosis and directly observed treatment: a qualitative study among patients from South India.

Authors:  Vijayashree Yellappa; Pierre Lefèvre; Tullia Battaglioli; Devadasan Narayanan; Patrick Van der Stuyft
Journal:  BMC Health Serv Res       Date:  2016-07-19       Impact factor: 2.655

9.  Tuberculosis and poverty: why are the poor at greater risk in India?

Authors:  Olivia Oxlade; Megan Murray
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

Review 10.  Financial burden for tuberculosis patients in low- and middle-income countries: a systematic review.

Authors:  Tadayuki Tanimura; Ernesto Jaramillo; Diana Weil; Mario Raviglione; Knut Lönnroth
Journal:  Eur Respir J       Date:  2014-02-13       Impact factor: 16.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.